EUVIMEDEUVIMED entdecken
Crossref

Simulation-driven optimization of insulin therapy profiles in a commercial hybrid closed-loop system

Jenny L Diaz C, María F Villa-Tamayo, Marcela Moscoso-Vasquez, Patricio Colmegna

Computer Methods and Programs in Biomedicine · 2023-12 · 242 · 107830

DOI: 10.1016/j.cmpb.2023.107830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Computer Methods and Programs in Biomedicine, 2023-12. Verfasst von Jenny L Diaz C und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Diabetes Technology, University of Virginia, Charlottesville, 22903, VA, USA. Electronic address: mut4vm@virginia.edu. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hyperglycemia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Automated insulin delivery (AID) has represented a breakthrough in managing type 1 diabetes (T1D), showing safe and effective glucose control extensively across the board. However, metabolic variability still poses a challenge to commercial hybrid closed-loop (HCL) solutions, whose performance depends on customizable insulin therapy profiles. In this work, we propose an Identification-Replay-Optimization (IRO) approach to optimize gradually and safely such profiles for the Control-IQ AID algorithm. METHODS: Closed-loop data are generated using the full adult cohort of the UVA/Padova T1D simulation platform in diverse glycemic scenarios. For each subject, daily records are processed and used to estimate a personalized model of the underlying insulin-glucose dynamics. Every two weeks, all identified models are integrated into an optimization procedure where daily basal and bolus profiles are adjusted so as to minimize the risks for hypo- and hyperglycemia. The proposed strategy is tested under different scenarios of metabolic and behavioral variability in order to evaluate the efficacy and convergence of the proposed strategy. Finally, glycemic metrics between cycles are compared using paired t-tests with p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HyperglycemiaAdultHumansInsulinHypoglycemic AgentsBlood GlucoseBlood Glucose Self-MonitoringInsulin Infusion Systems

Stichwörter der Autor:innen

Blood glucose controlDecision support systemsDiabetes mellitusInsulin delivery therapyOptimal insulin dosing

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Center for Diabetes Technology, University of Virginia, Charlottesville, 22903, VA, USA. Electronic address: mut4vm@virginia.edu.
  • Center for Diabetes Technology, University of Virginia, Charlottesville, 22903, VA, USA.

Zitieren

APA

Diaz C, J. L., Villa-Tamayo, M. F., Moscoso-Vasquez, M., & Colmegna, P. (2023). Simulation-driven optimization of insulin therapy profiles in a commercial hybrid closed-loop system. Computer Methods and Programs in Biomedicine, 242, 107830. https://doi.org/10.1016/j.cmpb.2023.107830

Vancouver

Diaz C JL, Villa-Tamayo MF, Moscoso-Vasquez M, Colmegna P. Simulation-driven optimization of insulin therapy profiles in a commercial hybrid closed-loop system. Computer Methods and Programs in Biomedicine. 2023;242:107830. doi:10.1016/j.cmpb.2023.107830

BibTeX
@article{DiazC2023,
  author = {Diaz C, Jenny L and Villa-Tamayo, María F and Moscoso-Vasquez, Marcela and Colmegna, Patricio},
  title = {Simulation-driven optimization of insulin therapy profiles in a commercial hybrid closed-loop system},
  journal = {Computer Methods and Programs in Biomedicine},
  year = {2023},
  volume = {242},
  pages = {107830},
  doi = {10.1016/j.cmpb.2023.107830}
}
Kostenlos starten →